Prevalence and risk factors of sleep breathing disorders in patients with acromegaly from Moscow region
- 作者: Kovaleva Y.1, Dreval A1, Kulakov N1, Fedorova S1, Ilovayskaya I1,2
-
隶属关系:
- Moscow Regional Research and Clinical Institute («MONIKI»)
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
- 期: 卷 90, 编号 10 (2018)
- 页面: 65-70
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32878
- DOI: https://doi.org/10.26442/terarkh201890104-70
- ID: 32878
如何引用文章
全文:
详细
作者简介
Yu Kovaleva
Moscow Regional Research and Clinical Institute («MONIKI»)к.м.н., с.н.с. отд-ния терапевтической эндокринологии МОНИКИ им. М.Ф. Владимирского Moscow, Russia
A Dreval
Moscow Regional Research and Clinical Institute («MONIKI»)д.м.н., проф., руководитель отд-ния терапевтической эндокринологии МОНИКИ им. М.Ф. Владимирского Moscow, Russia
N Kulakov
Moscow Regional Research and Clinical Institute («MONIKI»)врач отд-ния функциональной диагностики, МОНИКИ им. М.Ф. Владимирского Moscow, Russia
S Fedorova
Moscow Regional Research and Clinical Institute («MONIKI»)к.м.н., руководитель отд-ния функциональной диагностики МОНИКИ им. М.Ф. Владимирского Moscow, Russia
I Ilovayskaya
Moscow Regional Research and Clinical Institute («MONIKI»); A.I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
Email: irena.ilov@yandex.ru
к.м.н., с.н.с. отд-ния терапевтической эндокринологии МОНИКИ им. М.Ф. Владимирского, доц. каф. поликлинической терапии МГМСУ им. А.И. Евдокимова Moscow, Russia
参考
- Молитвословова Н.Н. Акромегалия. В кн.: Дедов И.И., Мельниченко Г.А., редакторы. Эндокринология. Национальное руководство. Москва: ГЭОТАР-Медиа; 2016. С. 766-777.
- Abreu A, Tovar A.P, Castellanos R, Valenzuela A, Giraldo C.M, Pinedo A.C, Guerrero D.P, Barrera C.A, Franco H.I, Ribeiro-Oliveira A.Jr, Vilar L, Jallad R.S, Duarte F.G, Gadelha M, Boguszewski C.L, Abucham J, Naves L.A, Musolino N.R, de Faria M.E, Rossato C, Bronstein M.D. Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary. 2016 Aug;19(4):448-457. doi: 10.1007/s11102-016-0725-2
- Attal P, Chanson P. Endocrine Aspects of Obstructive Sleep Apnea. J Clin Endocrinol Metab. 2010;95(2):483-495. doi: 10.1210/jc.2009-1912
- Ceccato F, Bernkopf E, Scaroni C. Sleep apnea syndrome in endocrine clinics. J Endocrinol Invest. 2015 Aug;38(8):827-834. doi: 10.1007/s40618-015-0338-z
- Senaratna C.V, Perret J.L, Lodge C, Lowe A, Campbell B.E, Matheson M.C, Hamilton G.S, Dharmage S.C. Prevalence of Obstructive Sleep Apnea in the general population: A systematic review. Sleep Med Rev. 2017 Aug;34:70-81. doi: 10.1016/j.smrv.2016.07.002
- Цой У.А., Коростовцева Л.С., Свиряев Ю.В., Семенов А.П., Ваулина Д.А., Кравченко С.О., Конради А.О., Гринева Е.Н. Распространенность нарушений дыхания во сне у больных с впервые выявленной акромегалией. Альманах клинической медицины. 2014 (32):36-42. doi: 10.18786/2072-0505-2014-32-36-42
- Davì M.V, Dalle Carbonare L, Giustina A, et al. Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol. 2008;159:533-540. doi: 10.1530/EJE-08-0442
- Pivonello R, Auriemma R.S, Grasso L.F, Pivonello C, Simeoli C, Patalano R, Galdiero M, Colao A. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary. 2017 Feb;20(1):46-62. doi: 10.1007/s11102-017-0797-7
- Powlson A.S, Gurnell M. Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly. Neuroendocrinology. 2016;103(1):75-85. doi: 10.1159/ 000438903
- Somers V.K, White D.P, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association council for high blood pressure research professional education committee, Council on clinical cardiology, Stroke council, and Council on cardiovascular nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080-1111. doi: 10.1161/Circulationaha.107.189375
- Kapur V.K, Auckley D.H, Chowdhuri S, Kuhlmann D.C, Mehra R, Ramar K, Harrod C.G. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An AmericanAcademy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017 Mar 15;13(3):479-504. doi: 10.5664/jcsm.6506
- Pedrosa R.P, Drager L.F, Gonzaga C.C, Sousa M.G, de Paula L.K, Amaro A.C, Amodeo C, Bortolotto L.A, Krieger E.M, Bradley T.D, Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011 Nov;58(5):811-817. doi: 10.1161/Hypertensionaha.111.179788
- Muxfeldt E.S, Margallo V.S, Guimarães G.M, Salles G.F. Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension. Am J Hypertens. 2014 Aug;27(8):1069-1078. doi: 10.1093/ajh/hpu023
- Tolis G, Angelopoulos N.G, Katounda E, et al. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs. Neuroendocrinology. 2006;83:249-257. doi: 10.1159/000095535
- Цой У.А., Свиряев Ю.В., Коростовцева Л.С., Семенов А.П., Ваулина Д.А., Непран В.И., Кравченко С.О., Конради А.О., Гринева Е.Н. Клинические особенности синдрома нарушения дыхания во сне у больных акромегалией. Терапевтический архив. 2015;(4):47-52. doi: 10.17116/terarkh201587447-52
- Berg C, Wessendorf T.E, Mortsch F, Forsting M, Teschler H, Weischer T, Mann K, Saller B, Herrmann B.L. Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. Eur J Endocrinol. 2009;161:829-835. doi: 10.1530/EJE-09-0694